Clinical Updates

Novartis’ Ilaris helps reduce patients’ symptoms and the frequency of attacks in two rare inflammatory diseases, mid-stage studies showed, as… »   

A group of scientists from the University of Copenhagen has created a model that shows how some types of ADHD… »   

Vertex Pharmaceuticals Inc reported a net loss for the third quarter on Thursday with results hurt by fast-declining sales of… »   

Germany’s largest drugmaker Bayer said it agreed with Schiff Nutrition International to take over the U.S. vitamins and nutritional supplements… »   

If you’re balding and want your hair to grow back, then here is some good news. A new research report… »   

Swiss drugmaker Novartis posted worse-than-expected third quarter sales on Thursday, dragged down by the loss of a U.S. patent on… »   

Clinical drug trials are a vital part of pharmaceutical manufacturers gaining approval for use by the U.S. Food and Drug… »   

GlaxoSmithKline Plc said results from five late-stage trials of two experimental quadrivalent influenza vaccines (QIV) met the main goal of… »   

Eli Lilly & Co’s experimental once-weekly diabetes drug dulaglutide proved superior in late-stage clinical trials to three other widely used… »   

Executives at the Boston-area pharmacy whose steroid shots have been linked to a deadly U.S. meningitis outbreak have been sued… »   

IT’S PAINFUL ENOUGH when a disease like West Nile virus sweeps the country, as it did this summer, causing 168… »   

Europe’s largest biotechnology company Actelion stuck to its guidance for mid single-digit core earnings growth in 2012 as the strong… »   

Parents worried about their toddlers have long turned to the WebMD website to check symptoms, but the popular site now… »   

Johnson & Johnson reported better-than-expected quarterly results on Tuesday, as prescription drug sales rebounded with the help of newer products… »   

A scientist who has spent his career at Duke University, Robert Lefkowitz, will share the 2012 Nobel Prize for… »